News | Cardiovascular Business | October 25, 2018

Average Age of U.S. Cardiologists Up While Income is Down

New survey of 2,600+ physicians reveals significant healthcare industry trends

Average Age of U.S. Cardiologists Up While Income is Down

October 25, 2018 — Overall cardiology compensation has dropped for the first time since 2014, according to the sixth annual Cardiovascular Provider Compensation & Production Survey from MedAxiom. In addition, the survey found the income gap between private and integrated groups widened in 2017.

Each year MedAxiom surveys its membership — more than one-third of all cardiology and cardiovascular groups in the country — on financial, staffing, productivity and compensation metrics, and a number of demographic measures. Data for the 2018 report was collected over the 2008-2017 time frame and includes 186 groups, representing 2,637 full-time physicians.

The 43-page report provides data and expert analysis on compensation and production trends by subspecialty, geographic region, ownership model and more. It looks at a variety of data points and factors including compensation per work relative value unit (wRVU), key cardiology volumes and ratios, diagnostic testing trends and the roles of advanced practice providers, part-time physicians as well as non-clinical roles.

Survey highlights include:

  • Overall cardiology compensation fell for the first time in three years to a median full-time equivalent (FTE) of $559,568;
  • Interventional physicians gained the top earnings spot from electrophysiologists;
  • Cardiologists in the South brought home over $120,000 more per FTE than those located in the Northeast;
  • Overall wRVUs remained flat while compensation per wRVU increased;
  • Nearly 40 percent of all cardiologists are age 56+ ; almost 25 percent are 61+; and
  • Cath volumes are flat, while nuclear volumes continue to trend downward.

In addition to the comprehensive data sections of the report, the 2018 MedAxiom Provider Compensation & Production Survey includes detailed analysis of the trends as well as an in-depth article on “What Patient Centric Care Really Means” by the survey’s author, Joel Sauer.

The full report can be accessed here.

For more information:


Related Content

ACC Combines NCDR, Accreditation Into New Quality Summit
News | Cardiovascular Business | March 15, 2019
The American College of Cardiology’s first annual ACC Quality Summit, held March 13-15 in New Orleans, merges the NCDR...
Diagnostic and Interventional Cardiology Named 2019 Azbee Awards Finalist for Social Media
News | Cardiovascular Business | March 08, 2019 | Jeff Zagoudis, Associate Editor
Diagnostic and Interventional Cardiology (DAIC) was named a finalist in the Social Media Presence category for the 2019...
 FDA Commissioner Scott Gottlieb Announces Resignation
News | Cardiovascular Business | March 05, 2019 | Jeff Zagoudis, Associate Editor
U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, M.D., resigned from his position March 5 after two...
Diagnostic and Interventional Cardiology Honored as Jesse H. Neal Awards Finalist

An example of the new transesophageal echo (TEE) visualization technology called TrueVue was shown at TCT 2018 for the first time. Philips’ new photo-realistic rendering is designed to offer a surgical view of cardiac structures to aid transcatheter procedural navigation.

News | Cardiovascular Business | February 25, 2019
Diagnostic and Interventional Cardiology has been recognized as a finalist in the Jesse H. Neal Awards for the third...
GE to Postpone Healthcare IPO Following Biopharmaceutical Business Sale
News | Cardiovascular Business | February 25, 2019 | Jeff Zagoudis, Associate Editor
GE Healthcare announced Feb. 25 the sale of its biopharmaceutical business to Danaher, and GE Chairman and CEO Larry...
Medical Bills Financially Burden Almost Half of Cardiovascular Disease Patients
News | Cardiovascular Business | February 11, 2019
Over 45 percent of adult atherosclerotic cardiovascular disease (ASCVD) patients suffer financial hardship related to...
Researchers raised the question whether an economic benefit should be assessed in FDA reviews. A large amount of the bill for atrial fibrillation catheter ablation procedures is the cost of the mapping and ablation catheters.

A large amount of the bill for atrial fibrillation catheter ablation procedures is the cost of the mapping and ablation catheters. Researchers raised the question whether an economic benefit should be assessed in FDA reviews. 

Feature | Cardiovascular Business | January 14, 2019 | Philip Jacobs, DPhil, Ilke Akpinar, M.D., Thanh Nguyen, M.D., Ph.D., Rupinder Sandhu, M.D., and Lars Thording Ph.D.
In an age when everything in medicine is now looked at though a cost vs. benefit analysis and U.S.
GE Submits Initial Public Offering Paperwork for Healthcare Division
News | Cardiovascular Business | December 19, 2018
As part of its plans to spin off its healthcare division into a separate company, GE reportedly submitted the paperwork...
Affordable Care Act Ruled Unconstitutional in Texas Federal Court
News | Cardiovascular Business | December 17, 2018
A judge of the Federal District Court for the Northern District of Texas ruled the Affordable Care Act (ACA)...
American Heart Association and The Joint Commission Merge Cardiac Certification Programs
News | Cardiovascular Business | October 15, 2018
The nation’s two leading cardiac accreditation and certification organizations are joining forces to offer a single...
Overlay Init